Confirm that you are 18 years or older to enter the store.
You are not old enough to visit the store.
This collection features full spectrum CBD oil from Hemnia, with concentrations ranging from 5% to 40% CBD per 10 ml bottle. You can choose between a hemp seed oil or MCT coconut oil carrier, either pure or with a flavour such as mint, lemon, or green tea. Taster packs allow you to compare different strengths or flavours before making a final choice.
Full-spectrum is a product specification indicating that an extract contains multiple components of the hemp plant, such as cannabinoids (CBD, CBG, CBC, or CBN) and terpenes, rather than exclusively isolated CBD. This describes the composition of the extract but does not automatically mean that the efficacy or safety of each individual product has been independently established.
CBD and THC are different cannabinoids from the hemp plant. According to the European Food Safety Authority (EFSA), CBD, unlike THC, is non-psychotropic. All oils in this collection contain less than 0.2% THC according to the product information; the exact THC content of a specific product can be found on its label or in its certificate of analysis.
The collection consists of 14 Hemnia full spectrum CBD oil products, each in a 10 ml bottle with a dropper. Strengths range from 5% to 40% CBD, which equates to 500 mg to 4000 mg of CBD per bottle. Intermediate concentrations of 10%, 15%, 20%, 25%, 30%, and 35% CBD oil allow for a gradual increase in strength.
Some of the oils use hemp seed oil as a carrier, such as the 5% to 30% CBD variants made from organically grown Swiss hemp. Other oils are dissolved in MCT coconut oil, a carrier with a neutral taste that is also used for the flavoured variants with mint, lemon, or green tea, and for the 40% CBD oil.
Would you like to compare before making a final choice? The 3-in-1 pack contains three flavoured oils, each 10% CBD (lemon, mint, and green tea, totalling 3000 mg CBD). The CBD oil kit includes four strengths in hemp oil (5%, 10%, 20%, and 30%, totalling 6500 mg CBD), allowing you to discover which concentration suits you best. Menobalance is a 10% CBD oil in MCT coconut oil with a terpene blend formulated for women during menopause.
When buying CBD oil, three pieces of information are important: the CBD percentage, the total amount of CBD in milligrams, and the bottle volume. A higher percentage does not automatically mean more total CBD, as this also depends on the bottle volume. In this collection, the volume is consistently 10 ml, meaning the percentage and milligram value increase proportionally: 10% represents 1000 mg, 20% represents 2000 mg, and so on.
Those who are unsure which strength suits them typically start with a lower concentration, such as 5% or 10% CBD oil, and gradually increase it. Taster packs with multiple strengths are suitable for this purpose. Regarding carrier oil: hemp seed oil has a rich, herbaceous flavour, while MCT coconut oil tastes more neutral and forms the base for the flavoured variants.
The oils in this collection are applied under the tongue with the included dropper and held for some time before swallowing. The appropriate number of drops varies per person; consult the packaging of your chosen product or a doctor or pharmacist for advice on use. This information is general in nature and does not replace medical advice.
According to the product information, these oils are not intended for children and are not recommended for pregnant or breastfeeding women.
The European Commission considers cannabidiol in a non-medicinal food context to be a novel food when the conditions of EU legislation are met. Novel foods may only be placed on the market in the EU when they have been authorised according to the applicable procedure.
The European Food Safety Authority (EFSA) concluded that the safety of CBD as a novel food could not be established based on the available data. EFSA reported insufficient data on, among other things, the liver, gastrointestinal tract, endocrine system, nervous system, and psychological well-being, and animal studies indicated potential reproductive toxicity. A safe upper limit (NOAEL) could not be determined.
These EFSA findings concern CBD as a substance in general and are not a statement about a specific Hemnia product. Use is not recommended during pregnancy and breastfeeding, and EFSA mentions additional uncertainty for individuals under 25 years of age and for people taking medication. Always consult a doctor or pharmacist if in doubt.
Some of the oils in this collection are, according to the product information, made from organically grown hemp and extracted via CO2 extraction; other characteristics mentioned for specific products include vegan and gluten-free. These properties vary per product and are listed on the product page, along with information on laboratory tests and the certificate of analysis for the respective batch.
Full spectrum CBD oil is a hemp extract that contains other cannabinoids, such as CBG, CBC, or CBN, and natural terpenes, in addition to CBD, rather than exclusively isolated CBD. This distinguishes it from CBD isolate. The term describes the composition of the extract and is not a medical claim about efficacy or effect.
CBD and THC are both cannabinoids from the hemp plant, but they differ: CBD is non-psychotropic according to EFSA, unlike THC. The oils in this collection contain less than 0.2% THC according to the product information. The exact THC content of a product can be found on its label or certificate of analysis.
EFSA could not establish the safety of CBD as a novel food based on the available data and reported insufficient data on, among other things, the liver, nervous system, and psychological well-being. A safe upper limit could not be determined. If in doubt or experiencing symptoms, always consult a doctor or pharmacist before using CBD oil.
EFSA indicates that the safety of CBD cannot currently be established for people taking medication. If you are taking medication, always consult a doctor or pharmacist before using full spectrum CBD oil from this collection, so that potential interactions can be assessed.